Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05644314

Efficacy of Drug-Eluting Vertebral Artery Stenting Treatment for Atherosclerotic Vertebral Arteries Stenosis

Led by Nanfang Hospital, Southern Medical University · Updated on 2023-03-14

144

Participants Needed

1

Research Sites

369 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a prospective, multi-center, open-access, single-arm trial to observe the real-world clinical efficacy of drug-eluting vertebral artery stenting system treatment for Atherosclerotic Vertebral Arteries Stenosis. Patients will be followed at 30 days, 6, and 12 months post-procedure and annually for 1 year within 3 years.

CONDITIONS

Official Title

Efficacy of Drug-Eluting Vertebral Artery Stenting Treatment for Atherosclerotic Vertebral Arteries Stenosis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older, any gender
  • Patients prescribed rapamycin drug-eluting vertebral artery stent systems
  • Patients and family members who understand the trial purpose and have signed informed consent
Not Eligible

You will not qualify if you...

  • Unable to receive dual antiplatelet therapy due to disease or severe coagulation problems
  • Severe infections, systemic diseases, uncontrollable hypertension, or contraindications for surgery
  • Presence of aneurysm that cannot be treated or is unsuitable for surgery
  • Active gastrointestinal bleeding
  • Heart attack or large stroke within the past 2 weeks
  • Known allergies to heparin, rapamycin, anesthesia, or contrast agents
  • Life expectancy less than 12 months
  • Investigator judges patient unsuitable for participation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Nanfang Hospital of Southern Medical University

Guangzhou, Guangdong, China, 510515

Actively Recruiting

Loading map...

Research Team

Z

Zhong Ji, PHD

CONTACT

K

Kaibin Huang

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here